(αS,3S,5aS,8aS,9aS)-Decahydro-9a-hydroxy-3-Methyl-1,4-dioxo-α-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid Ethyl Ester
- $500.48 - $2200
- Product name: (αS,3S,5aS,8aS,9aS)-Decahydro-9a-hydroxy-3-Methyl-1,4-dioxo-α-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid Ethyl Ester
- CAS: 1309040-96-7
- MF: C23H30N2O5
- MW: 414.49
- EINECS:
- MDL Number:MFCD30543643
- Synonyms:(αS,3S,5aS,8aS,9aS)-Decahydro-9a-hydroxy-3-Methyl-1,4-dioxo-α-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid Ethyl Ester;RaMipril IMpurity-L;9a-Hydroxy RaMipril Diketopiperazine;2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic acid, decahydro-9a-hydroxy-3-methyl-1,4-dioxo-α-(2-phenylethyl)-, ethyl ester, (αS,3S,5aS,8aS,9aS)-;2-(5-Methyl-4,7-dioxo-decahydro-3b,6-diaza-cyclopenta[a]inden-6-yl)-4-phenyl-butyric acid ethyl ester
2 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Medical Isotopes, Inc.
Package
- 5MG
- 250mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0026239
- Product description9A-HYDROXY RAMIPRIL DIKETOPIPERAZINE 95.00%
- Packaging5MG
- Price$500.48
- Updated2021-12-16
- Buy
- ManufacturerMedical Isotopes, Inc.
- Product number51797
- Product description9a-HydroxyRamiprilDiketopiperazine
- Packaging250mg
- Price$2200
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | API0026239 | 9A-HYDROXY RAMIPRIL DIKETOPIPERAZINE 95.00% | 5MG | $500.48 | 2021-12-16 | Buy |
Medical Isotopes, Inc. | 51797 | 9a-HydroxyRamiprilDiketopiperazine | 250mg | $2200 | 2021-12-16 | Buy |
Properties
solubility :Chloroform (Slightly), Methanol (Slightly)
form :Solid
color :White to Off-White
Stability :Hygroscopic
form :Solid
color :White to Off-White
Stability :Hygroscopic
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|